HOME >> BIOLOGY >> NEWS
Mechanism for Epstein-Barr virus protein's role in blood cancers discovered

Earlier this year, researchers at the University of Pennsylvania School of Medicine identified a link between a critical cancer pathway and an Epstein-Barr Virus (EBV) protein known to be expressed in a number of EBV-associated cancers. Their findings demonstrated a new mechanism by which EBV can transform human B cells from the immune system into cancerous cells, which can lead to B-cell lymphomas. Now, they have found that the viral protein--called EBNA3C (for EBV nuclear antigen)--mediates the degradation of the retinoblastoma protein, an important molecular brake for cell proliferation.

Erle S. Robertson, PhD, an Associate Professor of Microbiology who leads the Tumor Virology Program at Penn's Abramson Cancer Center, and MD/PhD student Jason Knight, published their results last week in the Proceedings of the National Academy of Sciences.

The retinoblastoma protein (Rb) is a major regulator of several genes in charge of cell proliferation and cell-cycle regulation. In the nucleus, Rb normally binds to E2F, turning off genes involved with cell proliferation. Using human cell cultures infected with the Epstein-Barr virus, the investigators found that EBNA3C recruits a group of molecules called the SCF complex, which attaches ubiquitin to Rb. This inadvertently tags Rb for degradation by the proteosome machinery, the cell's recycling plant. With Rb out of the way, the cell now reproduces uncontrollably.

"It's as simple as that, but it's a major mystery solved that many researchers have been working on for at least 15 years," says Robertson.

EBV, a member of the herpesvirus family and one of the most common human viruses, plays a role in cancers such as lymphoproliferative diseases in transplant or AIDS patients, Burkitt's lymphoma, Hodgkin's lymphoma, and nasopharyngeal carcinoma, and also causes the well-known disease infectious mononucleosis. As many as 95 percent of adults 20 years and older have been infected with EBV, but sho
'"/>

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine
23-Dec-2005


Page: 1 2

Related biology news :

1. Mechanism of microRNAs deciphered
2. Mechanisms involved with tumor relapse identified
3. Mechanism to organize nervous system conserved in evolution
4. Mechanism for memory revealed in neurons of electric fish
5. Mechanism of new sudden-death arrhythmia detailed
6. Mechanism regulating tooth shape formulation found
7. Mechanism proposed for link between RU-486 and fatal infections
8. Mechanism for the captation of nutrients in plants- unknown to date
9. Mechanism discovered for muscle wasting seen in diabetes, AIDS and other diseases
10. Malaria and Epstein-Barr virus linked to pediatric cancer in Africa
11. Clue found to Epstein-Barr virus ability to form and sustain tumors

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2019)... ... August 21, 2019 , ... ... line for rapid and low-cost biomanufacturing of complex protein therapeutics, today announced the ... of AbSci's Scientific Advisory Board, Dr. Larimore brings more than 30 years of ...
(Date:8/21/2019)... (PRWEB) , ... August 20, 2019 , ... ... experience for the second time since BioInformatics first fielded the survey in 2016. ... Life Science Customer Experience , from BioInformatics, part of Science and Medicine Group. ...
(Date:8/15/2019)... (PRWEB) , ... August 15, 2019 , ... Deep ... of their Food and Agriculture practice, a new unit dedicated to building 100 companies ... sustainable nutrition, raw materials and supply chains. , Deep Science Ventures was founded ...
Breaking Biology News(10 mins):
(Date:9/17/2019)... ... September 17, 2019 , ... ... in chronic diseases, announces today that the U.S. Patent and Trademark Office (USPTO) ... algorithm to rank drug class recommendations for hypertension treatment. , The patent ...
(Date:9/17/2019)... ... September 16, 2019 , ... A new episode of Advancements ... ET. Check local listings for more information on this program. , The show ... company from Singapore dedicated to developing advanced diagnostic technologies for the masses. Viewers ...
(Date:9/11/2019)... ... September 09, 2019 , ... Suvoda ... randomization and drug supply chain management, today announced its new technology partnership with ... industry. , “The integration between Veeva Vault EDC and our IRT will enable ...
(Date:9/9/2019)... , ... September 09, 2019 , ... Visikol CEO Dr. ... that was focused on how best to characterize 3D cell culture models. The inherent ... they are too thick and opaque to image through and therefore traditional wide-field or ...
Breaking Biology Technology:
Cached News: